Partner Headlines - LLY

  1. Acorda Could Rival Lilly's 'Novel' Migraine Drug With Faster ...

    Investors Business Daily
  2. Incyte Poised To Outperform Biotech Industry On Strong Pipeline

    Investors Business Daily
  3. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily
  4. Merck, Biogen, Lilly Top 2016 Drug Approvals Despite FDA Slump

    Investors Business Daily
  5. Trump Twitter Hangover Keeps Biotech Stocks Down

    TalkMarkets
  6. Lilly Regains Key Migraine Drug With $960 Million CoLucid Acquisition

    Investors Business Daily
  7. FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    Investors Business Daily
  8. Trump + Stocks: The Week In Review

    TalkMarkets
  9. Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug ...

    Investors Business Daily
  10. Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva

    Investors Business Daily
  11. Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In ...

    Investors Business Daily
  12. Two Key FDA Decisions To Watch Out For In January 2017

    TalkMarkets
  13. Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: ...

    Investors Business Daily
  14. J&J Back In Talks With Actelion, Teva Settles Corruption Probe

    TalkMarkets
  15. Gilead Is A Hail Mary: 3 Better Stocks To Consider

    TalkMarkets
  16. Two Lessons From My Biogen Trade

    TalkMarkets
  17. Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New ...

    TalkMarkets
  18. AskSlim Market Week - 12/16/16

    TalkMarkets
  19. The FDA: Small-Cap Catalyst Or Small-Cap Killer?

    TalkMarkets
  20. Lilly Spikes Post Alzheimer's Flop On Street-Topping 2017 Guidance

    Investors Business Daily
  21. Global Stocks Jump, Dow Set For 16th Post-Election Record High ...

    TalkMarkets
  22. Johnson & Johnson Boosted By Barron's Call For Rally

    TalkMarkets
  23. Will Trump Break With Republicans And Push Major Drug Price Reform?

    Investors Business Daily
  24. Biogen Underplays Promising Alzheimer's Data On Seizure Worries

    Investors Business Daily
  25. Biogen Alzheimer's Drug Shows More Promise; Lilly Data Tonight

    Investors Business Daily
  26. Week In Review: Suzhou's Innovent Biologics Announces Record ...

    TalkMarkets
  27. Lilly Could Pocket $1.7 Billion In Fresh Diabetes Drug Sales ...

    Investors Business Daily
  28. Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF

    TalkMarkets
  29. Askslim Market Week - 11/25/16

    TalkMarkets
  30. Eli Lilly Stock Suffers Setback With Alzheimer’s Drug Failure ...

    TalkMarkets
  31. Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink

    TalkMarkets
  32. Dow Jones Industrial Average Hits New Record In Afternoon Trading ...

    TalkMarkets
  33. Eli Lilly Shares Tank As Alzheimer Drug Fails Clinical Trial ...

    TalkMarkets
  34. Today's Trading Plan: The Bull Chaser

    TalkMarkets
  35. Paid To Wait? Eli Lilly Crashes To 2 Year Lows, Erases 6 Years ...

    TalkMarkets
  36. Morgan Stanley Expects Big Reversal Today In Biogen Shares

    TalkMarkets
  37. 5 Pharma Stocks In Focus On World Diabetes Day

    TalkMarkets
  38. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets
  39. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets
  40. Eli Lilly Plunges To 7 Month Lows After Bernie Sanders Tweet

    TalkMarkets
  41. Why After A Massive Run, CoLucid Shares Still Look Attractive ...

    TalkMarkets
  42. 5 Healthcare Stocks To Buy Despite A Clinton Victory

    TalkMarkets
  43. Merck & Co., Inc. Surges After Earnings, Eli Lilly and Co. Slips

    TalkMarkets
  44. Largest Dow Component 3M Reports In Line Earnings, Cuts Top End ...

    TalkMarkets
  45. Morning Call For October 25, 2016

    TalkMarkets
  46. Biotech Lilly Upgraded On Alzheimer's Drug's $7.5 Billion Potential

    IBD
  47. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets
  48. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to ...

    TalkMarkets
  49. Southern Company Leads 52 Stocks Going Ex-Dividend Next Week

    Dividend.com
  50. Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout

    Investors Business Daily
  51. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily
  52. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily
  53. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings ...

    Investors Business Daily
  54. Top Funds Heart Edward Lifesciences, Bump Lilly

    IBD
  55. Merck Stock Slides As Q4 Revenue, Guidance Miss Expectations

    IBD
  56. Earnings Recap For January 28

    Benzinga
  57. Eli Lilly Punished For Inline Report

    Benzinga
  58. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga
  59. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga
  60. Last-Hour Rally Erases Midday Losses As Indexes Close Mixed

    IBD
  61. Steven Cohen Makes Eli Lilly, Kraft Heinz Top New Buys

    GuruFocus
  62. A Calmer Year For Pharma?

    IBD
  63. 3 Potential Blockbuster Drugs Launching in 2016

    IBD
  64. Lilly Counts On Pipeline In '16

    IBD
  65. Lilly Guidance Misses Estimates On Lower Sales

    IBD
  66. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD
  67. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus
  68. Mairs and Power Sells Baxalta, Walt Disney, Target

    GuruFocus
  69. Strategic Beta ETFs Among Year's Top Performers

    IBD
  70. Benzinga's Top Upgrades

    Benzinga
  71. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD
  72. Cautious Stock Rebound as Jobs Data Delivers But Wages Still ...

    Benzinga
  73. Lilly Ends Basal Insulin Peglispro Development Program

    Benzinga
  74. HOTCHKIS & WILEY Buys More Than 7 Million Shares in Oil and Gas ...

    GuruFocus
  75. Merck

    IBD
  76. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD
  77. Amazon's PT Raised; Yum, J&J, Merck, Lilly Upgraded

    IBD
  78. Benzinga's Top Upgrades

    Benzinga
  79. Sanofi Chipping Away At Biogen's MS Dominance

    IBD
  80. Steven Cohen Hikes Stake in Microsoft by More Than 50,000%

    GuruFocus
  81. Biotechs Weaken, But These Names Have Bullish Charts

    IBD
  82. Eli Lilly Release Confirms FDA Approval If Portrazza

    Benzinga
  83. Lilly and Merck Expand Immuno-oncology Collaboration with Phase ...

    Benzinga
  84. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD
  85. PRIMECAP Sells Stake in Technology Company

    GuruFocus
  86. Benzinga's Top Upgrades

    Benzinga
  87. ELI LILLY

    IBD
  88. Lilly, Incyte Announce Data Demonstrate Baricitinib Superiority ...

    Benzinga
  89. DOJ Eyes Lilly, Merck Pricing

    IBD
  90. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  91. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  92. Sanofi, Novo Nordisk Slide On Diabetes Headwinds

    IBD
  93. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase ...

    Benzinga
  94. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD
  95. Eli Lilly CEO: Our Drug Prices are Fair

    FoxBusiness
  96. McDonald's Strong 3Q Helps Wall Street Jump

    FoxBusiness
  97. Eli Lilly Posts Upbeat Q3 Earnings, Raises Forecast

    Benzinga
  98. Eli Lilly Reports Mixed 3Q Results

    FoxBusiness
  99. Lilly supports global Dementia Discovery Fund

    Benzinga
  100. Wal-Mart's $21 Billion Loss Lost on NYSE Officials

    FoxBusiness
Trading Center